Literature DB >> 26074333

mRNA 3'-UTR shortening is a molecular signature of mTORC1 activation.

Jae-Woong Chang1, Wei Zhang2, Hsin-Sung Yeh1, Ebbing P de Jong1, Semo Jun1, Kwan-Hyun Kim1, Sun S Bae3, Kenneth Beckman4, Tae Hyun Hwang5, Kye-Seong Kim6, Do-Hyung Kim1, Timothy J Griffin1, Rui Kuang2, Jeongsik Yong1.   

Abstract

Mammalian target of rapamycin (mTOR) enhances translation from a subset of messenger RNAs containing distinct 5'-untranslated region (UTR) sequence features. Here we identify 3'-UTR shortening of mRNAs as an additional molecular signature of mTOR activation and show that 3'-UTR shortening enhances the translation of specific mRNAs. Using genetic or chemical modulations of mTOR activity in cells or mouse tissues, we show that cellular mTOR activity is crucial for 3'-UTR shortening. Although long 3'-UTR-containing transcripts minimally contribute to translation, 3-'UTR-shortened transcripts efficiently form polysomes in the mTOR-activated cells, leading to increased protein production. Strikingly, selected E2 and E3 components of ubiquitin ligase complexes are enriched by this mechanism, resulting in elevated levels of protein ubiquitination on mTOR activation. Together, these findings identify a previously uncharacterized role for mTOR in the selective regulation of protein synthesis by modulating 3'-UTR length of mRNAs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26074333     DOI: 10.1038/ncomms8218

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  48 in total

1.  Patterns of variant polyadenylation signal usage in human genes.

Authors:  E Beaudoing; S Freier; J R Wyatt; J M Claverie; D Gautheret
Journal:  Genome Res       Date:  2000-07       Impact factor: 9.043

Review 2.  Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression.

Authors:  Carol S Lutz; Alexandra Moreira
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-09-20       Impact factor: 9.957

3.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

4.  mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression.

Authors:  Bilgen Ekim; Brian Magnuson; Hugo A Acosta-Jaquez; Jennifer A Keller; Edward P Feener; Diane C Fingar
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

5.  TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.

Authors:  Yanan Guo; Yvonne Chekaluk; Jianming Zhang; Jinyan Du; Nathanael S Gray; Chin-Lee Wu; David J Kwiatkowski
Journal:  J Pathol       Date:  2013-03-21       Impact factor: 7.996

6.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

7.  A large-scale analysis of mRNA polyadenylation of human and mouse genes.

Authors:  Bin Tian; Jun Hu; Haibo Zhang; Carol S Lutz
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

8.  The role of RING box protein 1 in mouse oocyte meiotic maturation.

Authors:  Lin Zhou; Ye Yang; Juanjuan Zhang; Xuejiang Guo; Ye Bi; Xin Li; Ping Zhang; Junqiang Zhang; Min Lin; Zuomin Zhou; Rong Shen; Xirong Guo; Ran Huo; Xiufeng Ling; Jiahao Sha
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

9.  The translational landscape of mTOR signalling steers cancer initiation and metastasis.

Authors:  Andrew C Hsieh; Yi Liu; Merritt P Edlind; Nicholas T Ingolia; Matthew R Janes; Annie Sher; Evan Y Shi; Craig R Stumpf; Carly Christensen; Michael J Bonham; Shunyou Wang; Pingda Ren; Michael Martin; Katti Jessen; Morris E Feldman; Jonathan S Weissman; Kevan M Shokat; Christian Rommel; Davide Ruggero
Journal:  Nature       Date:  2012-02-22       Impact factor: 69.504

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  27 in total

1.  An integrative model for alternative polyadenylation, IntMAP, delineates mTOR-modulated endoplasmic reticulum stress response.

Authors:  Jae-Woong Chang; Wei Zhang; Hsin-Sung Yeh; Meeyeon Park; Chengguo Yao; Yongsheng Shi; Rui Kuang; Jeongsik Yong
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971

Review 2.  Levels of MicroRNA Heterogeneity in Cancer Biology.

Authors:  Nina Petrovic; Sercan Ergün; Esma R Isenovic
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

3.  The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome.

Authors:  Moritz Haneklaus; John D O'Neil; Andrew R Clark; Seth L Masters; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2017-03-16       Impact factor: 5.157

Review 4.  Alternative polyadenylation of mRNA precursors.

Authors:  Bin Tian; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-28       Impact factor: 94.444

5.  The TORC1-Regulated CPA Complex Rewires an RNA Processing Network to Drive Autophagy and Metabolic Reprogramming.

Authors:  Hong-Wen Tang; Yanhui Hu; Chiao-Lin Chen; Baolong Xia; Jonathan Zirin; Min Yuan; John M Asara; Leonard Rabinow; Norbert Perrimon
Journal:  Cell Metab       Date:  2018-03-29       Impact factor: 27.287

Review 6.  Alternative splicing in aging and longevity.

Authors:  Malini Bhadra; Porsha Howell; Sneha Dutta; Caroline Heintz; William B Mair
Journal:  Hum Genet       Date:  2019-12-13       Impact factor: 4.132

Review 7.  Alternative cleavage and polyadenylation in health and disease.

Authors:  Andreas J Gruber; Mihaela Zavolan
Journal:  Nat Rev Genet       Date:  2019-07-02       Impact factor: 53.242

8.  mTORC1 promotes cell growth via m6A-dependent mRNA degradation.

Authors:  Sungyun Cho; Gina Lee; Brian F Pickering; Cholsoon Jang; Jin H Park; Long He; Lavina Mathur; Seung-Soo Kim; Sunhee Jung; Hong-Wen Tang; Sebastien Monette; Joshua D Rabinowitz; Norbert Perrimon; Samie R Jaffrey; John Blenis
Journal:  Mol Cell       Date:  2021-03-22       Impact factor: 19.328

Review 9.  Alternative Polyadenylation of mRNAs: 3'-Untranslated Region Matters in Gene Expression.

Authors:  Hsin-Sung Yeh; Jeongsik Yong
Journal:  Mol Cells       Date:  2016-02-25       Impact factor: 5.034

10.  In silico model for miRNA-mediated regulatory network in cancer.

Authors:  Khandakar Tanvir Ahmed; Jiao Sun; William Chen; Irene Martinez; Sze Cheng; Wencai Zhang; Jeongsik Yong; Wei Zhang
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.